透明质酸
化学
姜黄素
纳米复合材料
阿霉素
细胞毒性
纳米载体
体外
癌细胞
癌症
药物输送
核化学
细胞凋亡
毒性
药理学
癌症研究
MTT法
肝癌
细胞培养
药品
Zeta电位
乳腺癌
纳米颗粒
细胞
生物物理学
生物医学工程
生物化学
粒径
生物相容性
咪唑
肝细胞癌
共轭体系
材料科学
肝细胞
纳米技术
细胞生长
作者
Walaa W. Oransa,Rasha F. K. Zahran,Rana R. El Sadda,Elshahat A. Toson
标识
DOI:10.1038/s41598-026-48707-9
摘要
Abstract Cancer continues to pose one of the biggest health burdens. Liver cancer has difficulties with early detection, efficient treatment and treatment resistance. Zeolitic imidazole framework-8(ZIF-8) is a type of metal organic frameworks (MOFs) that has a lot of useful properties; including its structural flexibility, high porosity and adjustable pore sizes, these make such framework good for drug delivery for hepatocellular carcinoma (HCC) and breast cancer. In the present study, curcumin was loaded into ZIF-8, and hyaluronic acid was applied as coat in a step-by-step, molar ratio, and pH-dependent manner. The resulting curcumin-loaded ZIF-8 (CZIF-8) and curcumin-loaded ZIF-8 coated with hyaluronic acid (CZIF-8/HA) nanocomposites were characterized by zeta potential, SEM, TEM, and PXRD. The obtained irregular semi-spherical nanocomposites have an average particle size of 127.93 and 131.07 nm; respectively. Also, their anticancer activities against two cancerous cell lines (HepG-2 and MDA-MB-231) and non-cancerous cell line (MCR-5) were assessed in vitro along with reference drug such as doxorubicin using the MTT assay. Additionally, the mechanisms by which these nanocomposites kill these tumor cells were found to involve apoptosis (elevated caspase-3 expression) rather than necrotic one and cell cycle arresting at G1/S phase. These particles have lower IC 50; particularly against HepG-2. Further, CZIF-8/HA demonstrated significantly higher cytotoxicity against cancer cells (HepG-2 and MDA-MB-231) compared to CZIF-8 and doxorubicin, while exhibiting minimal toxicity toward normal MRC-5 cells. These results imply that ZIF-8/HA is a promising nanocarrier for curcumin administration and could be used as a therapeutic strategy for breast and liver cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI